The Food and Drug Administrationinformed Canadian nuclear medicine vendor Park Medical Systemslast week that its Isocam 2 digital dual-head gamma camera hasbeen cleared for marketing. Park, of Lachine, Quebec, is now poisedto take a run at other
The Food and Drug Administrationinformed Canadian nuclear medicine vendor Park Medical Systemslast week that its Isocam 2 digital dual-head gamma camera hasbeen cleared for marketing. Park, of Lachine, Quebec, is now poisedto take a run at other manufacturers of digital cameras, as wellas variable-angle dual-head vendors ADAC Laboratories and SophaMedical.
Park debuted Isocam 2 at this year's Society of Nuclear Medicinemeeting in Orlando. The system features Park's spectral mode acquisitionin real time (SMART) digital detector, which is a departure fromAnger-based gamma cameras, according to the company. The cameraconverts analog nuclear signals to digital form within individualphotomultiplier tubes, thus enhancing its ability to positionand measure nuclear events.
Park's single-head digital camera, Isocam 1, received FDA clearancelast year (SCAN 2/19/93). Sales of Isocam 1 have been slow tomaterialize, however, due to the company's low profile and smallsales force. Isocam 2 will be Park's lead product as it buildsits sales and marketing team.
Isocam 2 has a robotic gantry that is capable of several distinctconfigurations, including 90º positioning for cardiac studies,as well as slip-ring rotation. The camera also supports simultaneousmulti-isotope imaging from 50 to 560 KeV and features large 22.3x 16.5-inch detectors in which the entire face of the detectoris available for clinical use. Park has also developed a remotediagnostic capability for its cameras, according to presidentand CEO Richard Mullen.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New Analysis Forecasts Substantial Cost Savings with the Use of Photon Counting CT for CCTA
March 8th 2025The use of ultra-high-resolution photon-counting CT in the evaluation of stable chest pain may significantly reduce follow-up tests and invasive coronary angiography (ICA) procedures, possibly resulting in millions in health-care cost savings, according to a cost-effectiveness analysis presented recently at the European Congress of Radiology.